Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Baxter International Inc.
Baxter International Inc. News
Baxter International Inc. Quantitative Score
About Baxter International Inc.
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Baxter International Inc. Earnings & Revenue
Baxter International Inc. Financials
Table Compare
Compare BAX metrics with: | |||
---|---|---|---|
Earnings & Growth | BAX | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | BAX | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | BAX | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | BAX | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Baxter International Inc. Income
Baxter International Inc. Balance Sheet
Baxter International Inc. Cash Flow
Baxter International Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
Metrics | Score |
---|---|
Discounted Cash Flows | Strong Buy |
Return on Equity | Strong Sell |
Return on Assets | Strong Sell |
Debt/Equity Ratio | Strong Sell |
Price/Earnings Ratio | Strong Sell |
Price/Book Ratio | Neutral |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Baxter International Inc. Dividends
Yield (TTM) | Dividend (TTM) | |
---|---|---|
Infinity% | 1.1600 |
Payment Date | Dividend | Frequency |
---|---|---|
2024-10-01 | 0.29 | Quarterly |
2024-07-01 | 0.29 | Quarterly |
2024-04-01 | 0.29 | Quarterly |
2024-01-02 | 0.29 | Quarterly |
2023-10-02 | 0.29 | Quarterly |
Baxter International Inc. Valuation
Project future cash flows and get the intrinsic value per share.
Historical Market Cap
Shares Outstanding
Baxter International Inc. Executives
Name | Role |
---|---|
Mr. Christopher A. Toth | Executive Vice President & Group President of Kidney Care |
Mr. Jose E. Almeida | Chairman of the Board, President & Chief Executive Officer |
Ms. Heather Knight | Executive Vice President & Group President of Medical Products and Therapies |
Mr. Alok Sonig B.E., Mba | Executive Vice President & Group President of Pharmaceuticals |
Mr. Joel T. Grade | Executive Vice President, Chief Financial Officer & Interim Chief Accounting Officer |
Name | Role | Gender | Date of Birth | Pay |
---|---|---|---|---|
Mr. Christopher A. Toth | Executive Vice President & Group President of Kidney Care | Male | 1979 | 5.26M |
Mr. Jose E. Almeida | Chairman of the Board, President & Chief Executive Officer | Male | 1962 | 3.62M |
Ms. Heather Knight | Executive Vice President & Group President of Medical Products and Therapies | Female | 1972 | 1.63M |
Mr. Alok Sonig B.E., Mba | Executive Vice President & Group President of Pharmaceuticals | Male | 1972 | 1.56M |
Mr. Joel T. Grade | Executive Vice President, Chief Financial Officer & Interim Chief Accounting Officer | Male | 1971 | 829.82K |
Baxter International Inc. Insider Trades
Date | 9 Sep |
Name | Craig Jeffrey A |
Role | Director |
Transaction | Acquired |
Type | A-Award |
Shares | 3472 |
Date | 8 Sep |
Name | Craig Jeffrey A |
Role | Director |
Transaction | Disposed |
Type | |
Shares | 0 |
Date | 3 Sep |
Name | Sonig Alok |
Role | EVP,Group President, Pharma |
Transaction | Disposed |
Type | F-InKind |
Shares | 3054 |
Date | 3 Sep |
Name | Borzi James W |
Role | EVP,Chief Supply Chain Officer |
Transaction | Disposed |
Type | F-InKind |
Shares | 1685 |
Date | 3 Jun |
Name | Toth Christopher A. |
Role | EVP,Group Pres, Kidney Care |
Transaction | Disposed |
Type | F-InKind |
Shares | 15202 |
Date | Name | Role | Transaction | Type | Shares |
---|---|---|---|---|---|
9 Sep | Craig Jeffrey A | Director | Acquired | A-Award | 3472 |
8 Sep | Craig Jeffrey A | Director | Disposed | 0 | |
3 Sep | Sonig Alok | EVP,Group President, Pharma | Disposed | F-InKind | 3054 |
3 Sep | Borzi James W | EVP,Chief Supply Chain Officer | Disposed | F-InKind | 1685 |
3 Jun | Toth Christopher A. | EVP,Group Pres, Kidney Care | Disposed | F-InKind | 15202 |